MK 571

CAS : 115104-28-4

Ref. 3D-QEA10428

Informations sur le produit

• Nom: MK 571
• Synonymes: 3-[({3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}{[3-(dimethylamino)-3-oxopropyl]sulfanyl}methyl)sulfanyl]propanoic acid, 3-[[[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl][[3-(dimethylamino)-3-oxopropyl]thio]methyl]thio]propanoic Acid Sodium Salt, 3-[[[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl][[3-(dimethylamino)-3-oxopropyl]thio]methyl]thio]propanoic acid, 3-{[(R)-{3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}{[3-(dimethylamino)-3-oxopropyl]sulfanyl}methyl]sulfanyl}propanoic acid, L 660711, L 660711, Sodium Salt, Mk-571, Mk-571 Na, Mk-571 Sodium Salt, Mk-571, Na Salt, Propanoic acid, 3-[[[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl][[3-(dimethylamino)-3-oxopropyl]thio]methyl]thio]-, Propanoic acid, 3-[[[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl][[3-(dimethylamino)-3-oxopropyl]thio]methyl]thio]-, (E)-, sodium 3-[({3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}{[3-(dimethylamino)-3-oxopropyl]sulfanyl}methyl)sulfanyl]propanoate

Description

MK 571 is a drug that inhibits the ATP-binding cassette (ABC) transporter. MK 571 has been shown to inhibit leukotriene production in hl-60 cells and increase ATP release from myocardial infarcted hearts. It also inhibits the activity of nonsteroidal anti-inflammatory drugs and has been shown to have synergistic effects with other chemotherapeutic agents in cancer treatment.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 515.09 g/mol
• Formule: C₂₆H₂₇ClN₂O₃S₂
• Degré de pureté: Min. 95%